testblu diagnostics
PrivateLast Round
Accelerator
Aug 1, 2024
Company Overview
testblu diagnostics is a biotechnology company that develops an AI-powered liquid biopsy platform for the early detection of cancer in dogs.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical AI, Healthcare Analytics, Precision Medicine
Business Model
B2B
Customer Profile
Usage-Based SaaS
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
testblu diagnostics Comparables
Compare testblu diagnostics with similar companies based on industry and business-model similarity.
testblu diagnostics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Accelerator | Aug 1, 2024 |
testblu diagnostics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| KU Leuven | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 1, 2024
Received funding from Silicon Allee and Veterinary Health Innovation Engine.
testblu diagnostics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about testblu diagnostics's valuation, stock price, and market status.
Is testblu diagnostics a public or private company?
testblu diagnostics is a private company.
What is the current stock price of testblu diagnostics?
testblu diagnostics is a private company, so its shares have no public market price. Caplight tracks testblu diagnostics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is testblu diagnostics worth (valuation)?
Valuation information for testblu diagnostics is not publicly available.
Can I buy testblu diagnostics stock?
testblu diagnostics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was testblu diagnostics's last funding round?
testblu diagnostics's most recent funding round was Accelerator on August 1, 2024.
Who are the main investors in testblu diagnostics?
Key investors in testblu diagnostics include KU Leuven.
Will testblu diagnostics IPO soon?
No public IPO plans have been announced for testblu diagnostics.
How can I track testblu diagnostics secondary market activity?
Caplight tracks bids, offers, and trades in testblu diagnostics's shares on secondary markets.